Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat

Go back to Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat

Mirum Pharmaceuticals, Inc. (MIRM) Trades at High, Up 158%

December 16, 2019 10:06 AM EST

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Trades at High, Up 158%

... More